9 Meters Biopharma, Inc. (MNTRQ) vs Seelos Therapeutics, Inc. (SEELQ)

9 Meters Biopharma, Inc. and Seelos Therapeutics, Inc. are both Biotechnology companies. 9 Meters Biopharma, Inc. is the larger, with a market value of $1.0M against $700.0K — 1.5× the size. 9 Meters Biopharma, Inc. grew revenue faster over the last twelve months: −50.8% against −51.5%. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, 9 Meters Biopharma, Inc. leads on 7 and Seelos Therapeutics, Inc. on 7.

Valuation

Metric MNTRQ SEELQ Biotechnology median
P/E n/m n/m 7.88
P/S 0.07 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.05 n/m 0.74
EV/Sales (0.54) 0.50 10.73
Earnings yield (17,300.00%) 0.00% (28.84%)
Free cash flow yield (13,701.96%) 0.00% (23.03%)

Profitability

Metric MNTRQ SEELQ Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,480.04%) 0.00%
Net margin 0.00% 203.13% 0.00%
Free cash flow margin 0.00% (659.09%) 0.00%
Return on equity (375.64%) (10.86%) (57.72%)
Return on assets (190.56%) 57.34% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MNTRQ SEELQ Biotechnology median
Revenue growth (TTM) (50.82%) (51.45%) 5.64%
EPS growth (last fiscal year) (12.67%) 62.72% —
Revenue growth, 5-year CAGR — (22.63%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNTRQ SEELQ Biotechnology median
Debt to equity (0.82) 0.00 0.00
Current ratio 0.59 0.08 4.73
Net debt to EBITDA (0.17) 0.09 0.96

Dividend

Metric MNTRQ SEELQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MNTRQ SEELQ Biotechnology median
Market cap 1.04m 700.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack